Liege, Belgium, 17 October 2022 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces its Phase 3 Topline Efficacy results for Donesta® were presented last Friday at the Annual Meeting of the North American Menopause Society (NAMS) held in Atlanta, Georgia.